World Diabetes Foundation
The World Diabetes Foundation is a leading global funder of projects and programmes for diabetes prevention and care in low- and middle-income countries. The foundation was established in 2002 by Novo Nordisk A/S with the vision to alleviate human suffering related to diabetes among those in greatest need.
The World Diabetes Foundation supports sustainable, scalable and policy-based approaches, helping countries meet global targets for improved care of diabetes and other non-communicable diseases. The foundation has been active in more than 100 countries and built partnerships with governments, civil society, the private sector and international agencies, and is also engaged in regional and global advocacy.
The World Diabetes Foundation provided USD 26.3 million for development in 2021 through its grantmaking activities. Compared to 2020, this amount represents a decrease of 3% in real terms.
In 2021, the World Diabetes Foundation provided USD 8.1 million to the multilateral system, representing 30.8% of its development finance, all of which was earmarked for specific countries, regions, themes or purposes.
All of this financing was channelled through the United Nations (UN) system, notably UNHCR (USD 7.2 million) and WHO (USD 0.9 million).
See the section on geographic and thematic focus for the geographical and thematic breakdown of bilateral allocations earmarked through the multilateral development system.
In 2021, the World Diabetes Foundation channelled its bilateral contributions mostly through public sector institutions (USD 8.6 million), non-governmental organisations (NGOs) and civil society (USD 8.5 million) and multilateral organisations (USD 8.1 million).
In 2021, the World Diabetes Foundation’s development finance was primarily focused on Africa, South Asia and the Middle East. USD 21.4 million was allocated to Africa, USD 3.1 million to South Asia and USD 1.1 million to the Middle East, accounting respectively for 81.1%, 11.7% and 4.2% of the foundation’s development finance. A sum of USD 0.8 million (3%) was unspecified by region in 2021.
In 2021, 64% of development finance went to the top 10 recipients. The World Diabetes Foundation’s most significant recipients included Kenya (USD 8.4 million), India (USD 1.6 million) and Rwanda (USD 1.5 million). Moreover, 30.4% of development finance was not allocated by country.
Least developed countries (LDCs) received USD 5 million (19%) of the World Diabetes Foundation’s development finance in 2021. The World Diabetes Foundation allocated the highest share of its development finance (44.7%) to lower middle income countries in 2021, noting that USD 8 million (30.4%) was unallocated by income group.
Official website: http://www.worlddiabetesfoundation.org/
The methodological notes provide further details on the definitions and statistical methodologies applied, including core and earmarked contributions to multilateral organisations, the Sustainable Development Goal focus of private development finance, channels of delivery, unspecified/unallocated allocations, the gender equality policy marker, and the environment markers.